These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Hirsutism, polycystic ovarian disease, and ovarian 17-ketosteroid reductase deficiency. Pang SY; Softness B; Sweeney WJ; New MI N Engl J Med; 1987 May; 316(21):1295-301. PubMed ID: 3472077 [TBL] [Abstract][Full Text] [Related]
5. [The differential diagnosis of hairy virilism in polycystic ovaries from adrenal cortical hirsutism]. Maleeva A; Milkov V; Visheva N; Kekhaĭova M Vutr Boles; 1990; 29(3):93-9. PubMed ID: 2178292 [TBL] [Abstract][Full Text] [Related]
6. Clinical presentation and etiologic factors of hirsutism in premenopausal Iranian women. Ansarin H; Aziz-Jalali MH; Rasi A; Soltani-Arabshahi R Arch Iran Med; 2007 Jan; 10(1):7-13. PubMed ID: 17198446 [TBL] [Abstract][Full Text] [Related]
7. Hirsutism and oligomenorrhea are appropriate screening criteria for polycystic ovary syndrome in adolescents. Villarroel C; López P; Merino PM; Iñiguez G; Sir-Petermann T; Codner E Gynecol Endocrinol; 2015; 31(8):625-9. PubMed ID: 26190534 [TBL] [Abstract][Full Text] [Related]
8. Heterogeneity of late-onset adrenal 3 beta-ol-hydroxysteroid dehydrogenase deficiency in patients with hirsutism and polycystic ovaries. Morán C; Tena G; Herrera J; Bermúdez JA; Zárate A Arch Med Res; 1994; 25(3):315-20. PubMed ID: 7803981 [TBL] [Abstract][Full Text] [Related]
9. Etiological review of hirsutism in 250 patients. Morán C; Tapia MC; Hernández E; Vázquez G; García-Hernández E; Bermúdez JA Arch Med Res; 1994; 25(3):311-4. PubMed ID: 7803980 [TBL] [Abstract][Full Text] [Related]
10. The benefits of finasteride for hirsute women with polycystic ovary syndrome or idiopathic hirsutism. Lakryc EM; Motta EL; Soares JM; Haidar MA; de Lima GR; Baracat EC Gynecol Endocrinol; 2003 Feb; 17(1):57-63. PubMed ID: 12724020 [TBL] [Abstract][Full Text] [Related]
11. Factors affecting the degree of hirsutism in patients with polycystic ovary syndrome. Guzel AI; Kuyumcuoğlu U; Celik Y Arch Gynecol Obstet; 2012 Mar; 285(3):767-70. PubMed ID: 21909749 [TBL] [Abstract][Full Text] [Related]
12. [Androgenization in patients with polycystic ovary syndrome]. Gasparov AS; Pshenichnikova TIa; Alieva EA; Fedorova TA; Vetr M Acta Univ Palacki Olomuc Fac Med; 1990; 126():241-6. PubMed ID: 2151091 [TBL] [Abstract][Full Text] [Related]
13. [FAI in hirsutism of women with polycystic ovary syndrome]. Jakimiuk A Ginekol Pol; 1992 Apr; 63(4):191-4. PubMed ID: 1303927 [TBL] [Abstract][Full Text] [Related]
14. Variants in the 5alpha-reductase type 1 and type 2 genes are associated with polycystic ovary syndrome and the severity of hirsutism in affected women. Goodarzi MO; Shah NA; Antoine HJ; Pall M; Guo X; Azziz R J Clin Endocrinol Metab; 2006 Oct; 91(10):4085-91. PubMed ID: 16849416 [TBL] [Abstract][Full Text] [Related]
15. Ovarian 17-ketosteroid reductase deficiency as a possible cause of polycystic ovarian disease. Toscano V; Balducci R; Bianchi P; Mangiantini A; Sciarra F J Clin Endocrinol Metab; 1990 Aug; 71(2):288-92. PubMed ID: 2166066 [TBL] [Abstract][Full Text] [Related]
16. Modified dexamethasone and gonadotropin-releasing hormone agonist (Dx-GnRHa) test in the evaluation of androgen source(s) in hirsute women. Bidzińska B; Tworowska U; Demissie M; Milewicz A Przegl Lek; 2000; 57(7-8):393-6. PubMed ID: 11109312 [TBL] [Abstract][Full Text] [Related]